Figures & data
Table 1. Bis(benzylidene)cyclohexanones studied in this work.
Table 2. Chemical structures of the reference inhibitors of Mpro and PLpro of SARS-CoV-2 or proteasome-associated deubiquitinating enzyme inhibitors included in this study.
Table 3. Determined IC50 and EC50 and cytotoxicity of selected reference inhibitors of cysteine proteases.
Table 4. Determined IC50 and EC50 values of bis(benzylidene)cyclohexanones T97 - T125 and reference inhibitors of proteasome-associated deubiquitinating enzymes RA-9 and RA-190.
Gao X, Qin B, Chen P, Zhu K, Hou P, Wojdyla JA, Wang M, Cui S. Crystal structure of sars-cov-2 papain-like protease. Acta Pharm Sin B. 2021;11(1):237–245. Cho CC, Li SG, Lalonde TJ, Yang KS, Yu G, Qiao Y, Xu S, Ray Liu W. Drug repurposing for the sars-cov-2 papain-like protease. ChemMedChem. 2022;17(1):e202100455. Lavaud M, Mullard M, Tesfaye R, Amiaud J, Legrand M, Danieau G, Brion R, Morice S, Regnier L, Dupuy M, et al. Overexpression of the ubiquitin specific proteases usp43, usp41, usp27x and usp6 in osteosarcoma cell lines: Inhibition of osteosarcoma tumor growth and lung metastasis development by the usp antagonist pr619. Cells. 2021;10(9):2268–2283. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-ncov) in vitro. Cell Res. 2020;30(3):269–271. Pizzorno A, Padey B, Dubois J, Julien T, Traversier A, Dulière V, Brun P, Lina B, Rosa-Calatrava M, Terrier O. In vitro evaluation of antiviral activity of single and combined repurposable drugs against sars-cov-2. Antiviral Res. 104878;181:104878. Fu Z, Huang B, Tang J, Liu S, Liu M, Ye Y, Liu Z, Xiong Y, Zhu W, Cao D, et al. The complex structure of grl0617 and sars-cov-2 plpro reveals a hot spot for antiviral drug discovery. Nat Commun. 2021;12(1):488. Ma C, Sacco MD, Hurst B, Townsend JA, Hu Y, Szeto T, Zhang X, Tarbet B, Marty MT, Chen Y, et al. Boceprevir, gc-376, and calpain inhibitors ii, xii inhibit sars-cov-2 viral replication by targeting the viral main protease. Cell Res. 2020;30(8):678–692. Fu L, Ye F, Feng Y, Yu F, Wang Q, Wu Y, Zhao C, Sun H, Huang B, Niu P, et al. Both boceprevir and gc376 efficaciously inhibit sars-cov-2 by targeting its main protease. Nat Commun. 2020;11(1):4417.